Date and CLASSIFICATION:

Brand Generic Route & CONTRA NURSING

Time Dosage MECHANISM OF INDICATIONS EVALUATION
Ordered
Name Name Frequency
ACTION INDICATIONS RESPONSIBILITIES
09/26/21 Plavix clopidogr 1 tablet PO, OD,  Binds to 1. To reduce 1. Active 1. Avoid clopidogrel in 1. The patient can
1:00 PM el after (PC) adenosine thrombotic pathological patients who have a already verbally
lunch diphosphate events, such bleeding, genetic variation in express reprieve of
(ADP) as MI and including CYP2C19 or are chest discomfort
receptors on stroke, in intracranial receiving CYP2C19 within the prescribed
the surface of patients with hemorrhage inhibitors. Platelet time period for
activated atherosclero and peptic inhibition may decline, medicines.
platelets. This sis ulcer; increasing the risk of 2. The patient's
action blocks documented hypersensiti adverse cardiovascular cardiovascular
ADP, which by recent MI, vity to effects after MI. stabilization, such as
deactivates peripheral clopidogrel 2. Determine if patient has blood pressure and
nearby artery or its a history of myocardial
glycoprotein disease, or components hypersensitivity that may contractility, is
IIb/IIIa stroke have included a managed within
receptors and 2. To reduce hematologic reaction to normal limits.
prevents the rate of any other thienopyridine 3. Patient receiving
fibrinogen from CVA and MI drug, such as prasugrel steps to avoid
attaching to in patient or ticlopidine, because bleeding and
receptors. with allergic cross-reactivity identifies indications
Without established has been reported. of bleeding that
fibrinogen, peripheral 3. Obtain blood cell count, should be
platelets can’t arterial as ordered, whenever addressed to a
aggregate and disease or a signs and symptoms medical expert right
form thrombi. history of suggest a hematologic once.
recent MI problem. 4. Patient does not
4. Monitor patient who suffer from bleeding
takes aspirin closely as demonstrated by
because risk of bleeding normal blood
is increased. pressure,
maintained
hematocrit and
plasma levels as
well as clotting
profile ranges that
are needed

This study source was downloaded by 100000806942661 from CourseHero.com on 03-24-2022 21:09:39 GMT -05:00
 Plavix (clopidogrel) Drug Study

This study source was downloaded by 100000806942661 from CourseHero.com on 03-24-2022 21:09:39 GMT -05:00
Powered by TCPDF (www.tcpdf.org)